Trials / Terminated
TerminatedNCT01818076
Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 311 (actual)
- Sponsor
- Revance Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the long-term safety of botulinum toxin type A for the treatment of moderate to severe crow's feet lines after repeat application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum Toxin Type A | Botulinum toxin type A, Dose A applied to the lateral canthal area |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-07-01
- Completion
- 2013-12-01
- First posted
- 2013-03-26
- Last updated
- 2014-05-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01818076. Inclusion in this directory is not an endorsement.